Novalgina

Novalgina is owned by Sanofi, headquartered in France. No. The ultimate owner of Novalgina, Sanofi, is headquartered in France, not in the United States.

Sanofi is a global pharmaceutical leader headquartered in France, focused on human health through vaccines, specialty care, and consumer healthcare products.

Sanofi Medley Farmacêutica Ltda.